Skip to main content
. Author manuscript; available in PMC: 2023 Mar 21.
Published in final edited form as: J Clin Psychol. 2019 Oct 17;76(1):31–39. doi: 10.1002/jclp.22874

TABLE 1.

Pre to posttreatment outcomes for transdiagnostic avoidance targeted by TBT

Intercept Slope p Value Effect size
MASA-behavioral avoidance 29.92 −8.64 <.001 0.71
APPQ-agoraphobia 20.07 −8.38 .005 0.45
PCL-5-situational avoidance 3.23 −1.01 <.001 0.72
MASA-physical arousal/avoidance 3.32 −1.1 .014 0.35
APPQ-interoceptive 29.54 −2.13 .284 0.21
MASA-thought avoidance 21.14 −4.52 .004 0.62
PCL-5-thought avoidance 2.25 −0.93 .002 0.66
MASA-anhedonia 27.06 −5.45 <.001 0.73
PCL-5-anhedonia 2.64 −1.32 <.001 0.88

Note: Intercept is the estimated baseline mean. Slope captures reductions from pre- to postintervention. Cohen’s d used for effect sizes.

Abbreviations: AAPQ, Albany Panic and Phobia Questionnaire; MASA, multidimensional assessment of social anxiety; PCL-5, PTSD checklist 5; TBT, transdiagnostic behavior therapy.